These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 28476806)

  • 1. Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Kanaji N; Kita N; Kadowaki N; Bandoh S
    Anticancer Res; 2017 May; 37(5):2393-2400. PubMed ID: 28476806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
    Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R
    Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network.
    Li Q; Wang W; Yamada T; Matsumoto K; Sakai K; Bando Y; Uehara H; Nishioka Y; Sone S; Iwakiri S; Itoi K; Utsugi T; Yasumoto K; Yano S
    Am J Pathol; 2011 Sep; 179(3):1483-93. PubMed ID: 21763682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.
    Kanaji N; Yokohira M; Nakano-Narusawa Y; Watanabe N; Imaida K; Kadowaki N; Bandoh S
    Respir Res; 2017 Jun; 18(1):118. PubMed ID: 28619066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
    Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
    Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.
    Jagirdar RM; Apostolidou E; Molyvdas PA; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
    Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L489-95. PubMed ID: 26773069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the met receptor in mesothelioma.
    Mukohara T; Civiello G; Davis IJ; Taffaro ML; Christensen J; Fisher DE; Johnson BE; Jänne PA
    Clin Cancer Res; 2005 Nov; 11(22):8122-30. PubMed ID: 16299245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
    Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
    Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
    Ohashi R; Tajima K; Takahashi F; Cui R; Gu T; Shimizu K; Nishio K; Fukuoka K; Nakano T; Takahashi K
    Anticancer Res; 2009 Jun; 29(6):2205-14. PubMed ID: 19528482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA; Taffaro ML; Salgia R; Johnson BE
    Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cells.
    Kuramitsu Y; Tominaga W; Baron B; Tokuda K; Wang Y; Kitagawa T; Nakamura K
    Anticancer Res; 2013 Jun; 33(6):2557-60. PubMed ID: 23749908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid inhibits fibronectin and laminin synthesis and cell migration of human pleural mesothelioma in vitro.
    Scarpa S; Giuffrida A; Palumbo C; Coletti A; Cerrito MG; Vasaturo F; Sinibaldi P; Simonelli L; Procopio A; Modesti A
    Oncol Rep; 2002; 9(1):205-9. PubMed ID: 11748484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HGF/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology.
    Harvey P; Warn A; Dobbin S; Arakaki N; Daikuhara Y; Jaurand MC; Warn RM
    Br J Cancer; 1998 Apr; 77(7):1052-9. PubMed ID: 9569039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma.
    Moriya M; Yamada T; Tamura M; Ishikawa D; Hoda MA; Matsumoto I; Klepetko W; Oda M; Yano S; Watanabe G
    Oncol Rep; 2014 Mar; 31(3):1109-15. PubMed ID: 24378576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
    Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
    Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway.
    Goudarzi H; Iizasa H; Furuhashi M; Nakazawa S; Nakane R; Liang S; Hida Y; Yanagihara K; Kubo T; Nakagawa K; Kobayashi M; Irimura T; Hamada J
    Cancer Lett; 2013 Oct; 339(1):82-92. PubMed ID: 23879962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
    Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
    Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.